Evidence map›Paper›PMID 29476273›Full record

ArticleThe AAPS journal2018

Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.

Chenxi Qu, Jizhao Li, Yejuan Zhou, Shudi Yang, Weiliang Chen, Fang Li, Bengang You, Yang Liu, Xuenong Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chenxi QuDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Jizhao LiDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Yejuan ZhouDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Shudi YangDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Weiliang ChenDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Fang LiDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Bengang YouDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Yang LiuDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China.
Xuenong ZhangDepartment of Pharmaceutics, College of Pharmaceutical Sciences, DuShuHu High Education Zone, Soochow University, Suzhou, 215123, Jiang Su Province, People's Republic of China. zhangxuenong@163.com.
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low accumulation in tumor sites and slow intracellular drug release remain as the obstacles for nanoparticles to achieve effective delivery of chemotherapeutic drugs. In this study, multifunctional micelles were designed to deliver doxorubicin (Dox) to tumor sites to provide more efficient therapy against hepatic carcinoma. The micelles were based on pH-responsive carboxymethyl chitosan (CMCh) modified with a reactive oxygen species (ROS)-responsive segment phenylboronic acid pinacol ester (BAPE) and an active targeted ligand CD147 monoclonal antibody. The Dox-loaded micelles provided rapid and complete drug release in pH 5.3 incubation conditions with 1 mM H

Indexed as

AnimalsAntibiotics, AntineoplasticAntibodies, MonoclonalBasiginCarcinoma, HepatocellularCell Line, TumorDelayed-Action PreparationsDoxorubicinDrug Delivery SystemsFemaleHumansHydrogen-Ion ConcentrationLiver NeoplasmsMiceMice, Inbred BALB CMicellesAntibiotics, AntineoplasticAntibodies, MonoclonalBasiginDelayed-Action PreparationsDoxorubicinMicellesReactive Oxygen SpeciesCD147doxorubicinmicellesROS/pH dual sensitivity

Identifiers

PMID29476273
OpenAlexW2789030661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.